Latest Articles
Weight-loss drugs now linked to cancer protection in women, major new study reveals - WCCS AM1160 & 101.1FM
Weight-loss drugs now linked to cancer protection in women, major new study reveals WCCS AM1160 & 101.1FM
Published: Sept. 29, 2025, 11:37 a.m.
Weight-loss drugs now linked to cancer protection in women, major new study reveals - Fox News
Weight-loss drugs now linked to cancer protection in women, major new study reveals Fox News
Published: Sept. 29, 2025, 11 a.m.
'No human data' to support use of soursop leaf tea to cure cancer: experts - AFP Fact Check
'No human data' to support use of soursop leaf tea to cure cancer: experts AFP Fact Check
Published: Sept. 29, 2025, 9:39 a.m.
Insurance coverage for GSK's Jemperli expanded to 1st-line endometrial cancer in Korea - koreabiomed.com
Insurance coverage for GSK's Jemperli expanded to 1st-line endometrial cancer in Korea koreabiomed.com
Published: Sept. 29, 2025, 8:16 a.m.
Ibuprofen Use Linked to Lower Risk of Endometrial Cancer - Oncology Nurse Advisor
Ibuprofen Use Linked to Lower Risk of Endometrial Cancer Oncology Nurse Advisor
Published: Sept. 29, 2025, 4 a.m.
Vancouver Island women's cancer treatment could get an AI boost - Ladysmith Chemainus Chronicle
Vancouver Island women's cancer treatment could get an AI boost Ladysmith Chemainus Chronicle
Published: Sept. 28, 2025, 8:02 p.m.
Vancouver Island women's cancer treatment could get an AI boost - Vancouver Island Free Daily
Vancouver Island women's cancer treatment could get an AI boost Vancouver Island Free Daily
Published: Sept. 28, 2025, 2 p.m.
Clinicopathological Characteristics and Oncologic Outcomes of Endometrioid Ovarian Carcinoma: A Retrospective Study from a Tertiary Cancer Centre.
Background/Objectives: To evaluate the clinicopathological features, treatment, and survival outcomes and to identify independent prognosticators for recurrence and mortality in patients with endometrioid ovarian cancer. Methods: The medical records of …
Published: Sept. 28, 2025, midnight
ASCENT-Gyn-01 Trial of Sacituzumab Govitecan Aims to Validate Clinical Utility of TROP2 ADCs in Pretreated Endometrial Cancer - OncLive
ASCENT-Gyn-01 Trial of Sacituzumab Govitecan Aims to Validate Clinical Utility of TROP2 ADCs in Pretreated Endometrial Cancer OncLive
Published: Sept. 26, 2025, 7:40 p.m.
UNM’s Kimberly Leslie awarded $12.9M NCI grant to study endometrial cancer - The Cancer Letter
UNM’s Kimberly Leslie awarded $12.9M NCI grant to study endometrial cancer The Cancer Letter
Published: Sept. 26, 2025, 7:28 p.m.
Link copied to clipboard!